Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Morphine 60mg modified-release tablets
0407020Q0AAAIAI
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 3,452 |
|
MST Continus 100mg tablets
0407020Q0BBADAH
|
MST Continus | Morphine sulfate | Central Nervous System | 2,447 |
|
Morphine sulfate 30mg/1ml solution for injection ampoules
0407020Q0AAADAD
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 1,557 |
|
Actimorph 5mg orodispersible tablets
0407020Q0BQAFGJ
|
Actimorph | Morphine sulfate | Central Nervous System | 1,306 |
|
Morphine sulfate 20mg/ml oral solution sugar free
0407020Q0AAA6A6
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 1,301 |
|
Actimorph 2.5mg orodispersible tablets
0407020Q0BQAAGE
|
Actimorph | Morphine sulfate | Central Nervous System | 1,043 |
|
Morphgesic SR 60mg tablets
0407020Q0BNACAI
|
Morphgesic | Morphine sulfate | Central Nervous System | 994 |
|
Morphine 5mg orodispersible tablets sugar free
0407020Q0AAGJGJ
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 988 |
|
Sevredol 50mg tablets
0407020Q0BHAFDR
|
Sevredol | Morphine sulfate | Central Nervous System | 920 |
|
Zomorph 200mg modified-release capsules
0407020Q0BKAEEI
|
Zomorph | Morphine sulfate | Central Nervous System | 896 |
|
Oramorph 20mg/ml concentrated oral solution
0407020Q0BCABA6
|
Oramorph | Morphine sulfate | Central Nervous System | 894 |
|
Morphine 2.5mg orodispersible tablets sugar free
0407020Q0AAGEGE
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 868 |
|
Morphine 100mg modified-release capsules
0407020Q0AAEBEB
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 790 |
|
Actimorph 10mg orodispersible tablets
0407020Q0BQABGF
|
Actimorph | Morphine sulfate | Central Nervous System | 766 |
|
Morphine 100mg modified-release tablets
0407020Q0AAAHAH
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 711 |
|
MXL 60mg capsules
0407020Q0BIABEH
|
MXL | Morphine sulfate | Central Nervous System | 613 |
|
MXL 30mg capsules
0407020Q0BIAAEG
|
MXL | Morphine sulfate | Central Nervous System | 581 |
|
Morphine 50mg tablets
0407020Q0AADRDR
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 467 |
|
Morphine sulfate 20mg/1ml solution for injection ampoules
0407020Q0AAAFAF
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 406 |
|
Morphine 10mg orodispersible tablets sugar free
0407020Q0AAGFGF
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 394 |
|
MST Continus 200mg tablets
0407020Q0BBAEAG
|
MST Continus | Morphine sulfate | Central Nervous System | 377 |
|
Morphine 20mg modified-release granules sachets sugar free
0407020Q0AACVCV
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 370 |
|
Morphine sulfate 10mg/10ml solution for injection ampoules
0407020Q0AAGAGA
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 363 |
|
MXL 90mg capsules
0407020Q0BIACDU
|
MXL | Morphine sulfate | Central Nervous System | 349 |
|
MST Continus suspension 20mg granules sachets
0407020Q0BBAFCV
|
MST Continus | Morphine sulfate | Central Nervous System | 325 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.